Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor
- PMID: 16339914
- DOI: 10.1124/jpet.105.096016
Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor
Abstract
Adenosine is elaborated in injured tissues where it suppresses inflammatory responses of essentially all immune cells, including production of proinflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha). Most of the anti-inflammatory actions of adenosine have been attributed to signaling through the A(2A) adenosine receptor (A(2A)AR). Previously, however, it has been shown that the A(3)AR agonist N(6)-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide (IB-MECA) potently inhibited TNF-alpha release from macrophages obtained from A(2A)AR "knockout" (A(2A)KO) mice, suggesting that the A(3)AR may also regulate cytokine expression. Here, we confirmed that the A(2A)AR is the primary AR subtype that suppresses TNF-alpha release from thioglycollate-elicited mouse peritoneal macrophages induced by both Toll-like receptor-dependent (TLR) and TLR-independent stimuli, but we determined that the A(2B)AR rather than the A(3)AR mediates the non-A(2A)AR actions of adenosine since 1) the ability of IB-MECA to inhibit TNF-alpha release was not altered in macrophages isolated from A(3)KO mice, and 2) the A(2B)AR antagonist 1,3-dipropyl-8-[4-[((4-cyanophenyl)carbamoylmethyl)oxy]phenyl]xanthine (MRS 1754) blocked the ability of the nonselective AR agonist adenosine-5'-N-ethylcarboxamide (NECA) to inhibit TNF-alpha release from macrophages isolated from A(2A)KO mice. Although A(2B)ARs seem capable of inhibiting TNF-alpha release, the A(2A)AR plays a dominant suppressive role since MRS 1754 did not block the ability of NECA to inhibit TNF-alpha release from macrophages isolated from wild-type (WT) mice. Furthermore, the potency and efficacy of adenosine to inhibit TNF-alpha release from WT macrophages were not influenced by blocking A(2B)ARs with MRS 1754. The data indicate that adenosine suppresses TNF-alpha release from macrophages primarily via A(2A)ARs, although the A(2B)AR seems to play an underlying inhibitory role that may contribute to the anti-inflammatory actions of adenosine under select circumstances.
Similar articles
-
Adenosine suppresses lipopolysaccharide-induced tumor necrosis factor-alpha production by murine macrophages through a protein kinase A- and exchange protein activated by cAMP-independent signaling pathway.J Pharmacol Exp Ther. 2009 Dec;331(3):1051-61. doi: 10.1124/jpet.109.157651. Epub 2009 Sep 11. J Pharmacol Exp Ther. 2009. PMID: 19749080 Free PMC article.
-
Effect of A2B adenosine receptor gene ablation on adenosine-dependent regulation of proinflammatory cytokines.J Pharmacol Exp Ther. 2008 Feb;324(2):694-700. doi: 10.1124/jpet.107.131540. Epub 2007 Oct 26. J Pharmacol Exp Ther. 2008. PMID: 17965229
-
Differential effects of adenosine A2a and A2b receptors on cardiac contractility.Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H2082-9. doi: 10.1152/ajpheart.00511.2010. Epub 2010 Oct 8. Am J Physiol Heart Circ Physiol. 2010. PMID: 20935155 Free PMC article.
-
Adenosine receptors and cancer.Handb Exp Pharmacol. 2009;(193):399-441. doi: 10.1007/978-3-540-89615-9_14. Handb Exp Pharmacol. 2009. PMID: 19639290 Free PMC article. Review.
-
Adenosine receptor-mediated cardioprotection: are all 4 subtypes required or redundant?J Cardiovasc Pharmacol Ther. 2012 Mar;17(1):21-33. doi: 10.1177/1074248410396877. Epub 2011 Feb 18. J Cardiovasc Pharmacol Ther. 2012. PMID: 21335481 Review.
Cited by
-
Tissue-derived proinflammatory effect of adenosine A2B receptor in lung ischemia-reperfusion injury.J Thorac Cardiovasc Surg. 2010 Oct;140(4):871-7. doi: 10.1016/j.jtcvs.2010.06.051. Epub 2010 Jul 24. J Thorac Cardiovasc Surg. 2010. PMID: 20659747 Free PMC article.
-
Mesothelioma Malignancy and the Microenvironment: Molecular Mechanisms.Cancers (Basel). 2021 Nov 12;13(22):5664. doi: 10.3390/cancers13225664. Cancers (Basel). 2021. PMID: 34830817 Free PMC article. Review.
-
The immunomodulatory function of adenosine in sepsis.Front Immunol. 2022 Jul 25;13:936547. doi: 10.3389/fimmu.2022.936547. eCollection 2022. Front Immunol. 2022. PMID: 35958599 Free PMC article. Review.
-
Novel long-chain compounds with both immunomodulatory and MenA inhibitory activities against Staphylococcus aureus and its biofilm.Sci Rep. 2017 Jan 10;7:40077. doi: 10.1038/srep40077. Sci Rep. 2017. PMID: 28071679 Free PMC article.
-
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases.Nat Rev Drug Discov. 2008 Sep;7(9):759-70. doi: 10.1038/nrd2638. Nat Rev Drug Discov. 2008. PMID: 18758473 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials